Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-1978 | |
Sales | 1,882,628 |
Cost of Goods | 714,289 |
Gross Profit | 1,168,339 |
Operating Expenses | 694,231 |
Operating Income | 474,397 |
Interest Expense | 17,867 |
Other Income | 30,956 |
Pre-tax Income | 487,486 |
Income Tax | 207,234 |
Net Income Continuous | 280,252 |
Net Income | $280,252 |
EBITDA(a) | $474,397 |